세계의 네트워크 POC 혈당 검사기 시장 규모 조사 및 예측 : 유형별(0.5uL, 1uL, 5uL, 기타), 용도별(병원, 진료소, 가정), 지역별 분석(2023-2030년)

Global Network Point-of-Care Glucose Testing Device Market is valued at approximately USD xxx billion in 2022 and is anticipated to grow with a healthy growth rate of more than xxx% over the forecast period 2023-2030. A network point-of-care glucose testing device is a medical device used to measure blood glucose levels in real-time at the point of care, such as a hospital, clinic, or doctor's office. This device is connected to a network, which allows for data transfer and sharing, enabling remote monitoring and management of patients with diabetes. The Network Point-of-Care Glucose Testing Device market is expanding because of factors such as increasing cases of diabetes and growing demand for medical testing kits. Network point-of-care glucose testing devices can provide an efficient and effective means of managing diabetes by allowing for real-time glucose monitoring, data sharing, and remote management, leading to improved patient outcomes and quality of care. Its prevalence has progressively increased during the last few decades.

According to the World Health Organization, diabetes affected 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, as per the International Diabetes Federation, the total number is predicted to rise to 643 million by 2030 and to 783 million by 2045. An estimated 44.7% of adults living with diabetes are undiagnosed and over 81% of these people live in low- and middle-income countries. Diabetes was responsible for an estimated USD 966 billion in global health expenditure in 2021. Another major component driving space is growing demand for medical testing kits. According to Statista, the sales of medical devices generated revenue of USD 480.97 billion in 2021. Revenue from medical devices was forecast to grow even further in the following years, reaching USD 570.80 billion by 2024. In addition, in 2021, 42 percent of healthcare organizations in the European Union were employing AI technologies for disease identification, with an additional 19% intending to carry out within the next three years. Also, increasing demand to incorporate patient data and rising government initiatives for diagnosis of diabetes would create a lucrative growth prospectus for the market over the forecast period. However, the high cost of Network Point-of-Care Glucose Testing Devices stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Network Point-of-Care Glucose Testing Device Market study include: Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 due to of the region's rising disease prevalence. Furthermore, Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as growing geriatric and target demographics, as well as regional growth of main market participants.

Major market players included in this report are:

• F. Hoffmann-La Roche AG
• Danaher Corporation
• Abbott Laboratories
• Nipro India Corporation Pvt Ltd.
• Nova Biomedical
• ACON Laboratories, Inc.
• Trividia Health, Inc.
• Prodigy Diabetes Care, LLC
• Bayer AG/Ascensia Diabetes Care Holdings AG
• EKF Diagnostics

Recent Developments in the Market:

• In October 2022, Roche launched a quick antigen diagnostic kit for detecting the COVID-19 coronavirus, with three additional configurations to be tested at home as well as by healthcare professionals.

Global Network Point-of-Care Glucose Testing Device Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered:Application, Type, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

by Type

• 0.5uL
• 1uL
• 5uL
• Others

By Application

• Hospital
• Clinic
• Household

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Network Point-of-Care Glucose Testing Device Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Network Point-of-Care Glucose Testing Device Market, by Type, 2020-2030 (USD Billion)
  • 1.2.3. Network Point-of-Care Glucose Testing Device Market, by Application, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Network Point-of-Care Glucose Testing Device Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Network Point-of-Care Glucose Testing Device Market Dynamics

• 3.1. Network Point-of-Care Glucose Testing Device Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing cases of diabetes
    • 3.1.1.2. Growing demand for medical testing kits
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Network Point-of-Care Glucose Testing Devices
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing demand to incorporate patient data.
    • 3.1.3.2. Rising government initiatives for diagnosis of diabetes

Chapter 4. Global Network Point-of-Care Glucose Testing Device Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Network Point-of-Care Glucose Testing Device Market, by Type

• 5.1. Market Snapshot
• 5.2. Global Network Point-of-Care Glucose Testing Device Market by Type, Performance - Potential Analysis
• 5.3. Global Network Point-of-Care Glucose Testing Device Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
• 5.4. Network Point-of-Care Glucose Testing Device Market, Sub Segment Analysis
  • 5.4.1. 0.5uL
  • 5.4.2. 1uL
  • 5.4.3. 5uL
  • 5.4.4. Others

Chapter 6. Global Network Point-of-Care Glucose Testing Device Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Network Point-of-Care Glucose Testing Device Market by Application, Performance - Potential Analysis
• 6.3. Global Network Point-of-Care Glucose Testing Device Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Network Point-of-Care Glucose Testing Device Market, Sub Segment Analysis
  • 6.4.1. Hospital
  • 6.4.2. Clinic
  • 6.4.3. Household

Chapter 7. Global Network Point-of-Care Glucose Testing Device Market, Regional Analysis

• 7.1. Top Leading Countries
• 7.2. Top Emerging Countries
• 7.3. Network Point-of-Care Glucose Testing Device Market, Regional Market Snapshot
• 7.4. North America Network Point-of-Care Glucose Testing Device Market
  • 7.4.1. U.S. Network Point-of-Care Glucose Testing Device Market
    • 7.4.1.1. Type breakdown estimates & forecasts, 2020-2030
    • 7.4.1.2. Application breakdown estimates & forecasts, 2020-2030
  • 7.4.2. Canada Network Point-of-Care Glucose Testing Device Market
• 7.5. Europe Network Point-of-Care Glucose Testing Device Market Snapshot
  • 7.5.1. U.K. Network Point-of-Care Glucose Testing Device Market
  • 7.5.2. Germany Network Point-of-Care Glucose Testing Device Market
  • 7.5.3. France Network Point-of-Care Glucose Testing Device Market
  • 7.5.4. Spain Network Point-of-Care Glucose Testing Device Market
  • 7.5.5. Italy Network Point-of-Care Glucose Testing Device Market
  • 7.5.6. Rest of Europe Network Point-of-Care Glucose Testing Device Market
• 7.6. Asia-Pacific Network Point-of-Care Glucose Testing Device Market Snapshot
  • 7.6.1. China Network Point-of-Care Glucose Testing Device Market
  • 7.6.2. India Network Point-of-Care Glucose Testing Device Market
  • 7.6.3. Japan Network Point-of-Care Glucose Testing Device Market
  • 7.6.4. Australia Network Point-of-Care Glucose Testing Device Market
  • 7.6.5. South Korea Network Point-of-Care Glucose Testing Device Market
  • 7.6.6. Rest of Asia Pacific Network Point-of-Care Glucose Testing Device Market
• 7.7. Latin America Network Point-of-Care Glucose Testing Device Market Snapshot
  • 7.7.1. Brazil Network Point-of-Care Glucose Testing Device Market
  • 7.7.2. Mexico Network Point-of-Care Glucose Testing Device Market
• 7.8. Middle East & Africa Network Point-of-Care Glucose Testing Device Market
  • 7.8.1. Saudi Arabia Network Point-of-Care Glucose Testing Device Market
  • 7.8.2. South Africa Network Point-of-Care Glucose Testing Device Market
  • 7.8.3. Rest of Middle East & Africa Network Point-of-Care Glucose Testing Device Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
  • 8.1.1. Company 1
  • 8.1.2. Company 2
  • 8.1.3. Company 3
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. F. Hoffmann-La Roche AG
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Recent Developments
  • 8.3.2. Danaher Corporation
  • 8.3.3. Abbott Laboratories
  • 8.3.4. Nipro India Corporation Pvt Ltd.
  • 8.3.5. Nova Biomedical
  • 8.3.6. ACON Laboratories, Inc.
  • 8.3.7. Trividia Health, Inc.
  • 8.3.8. Prodigy Diabetes Care, LLC
  • 8.3.9. Bayer AG/Ascensia Diabetes Care Holdings AG
  • 8.3.10. EKF Diagnostics

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption